Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors
Status:
Completed
Trial end date:
2020-01-20
Target enrollment:
Participant gender:
Summary
Participants in this study have been diagnosed with a tumor such as a carcinoid,
neuroendocrine tumor, neuroblastoma, Ewing's sarcoma, or brain tumor that has cells which
carry somatostatin receptors.
The purpose of this research study is to see if the tumor can be identified using a special
procedure called a positron emission tomography (PET) scan and how the results of this
imaging procedure will change the management of the tumor.